Day Two at ACHEMA - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Day Two at ACHEMA



Another day and I’ve seen many more technologies here in Frankfurt at ACHEMA.

AVEVA have unveiled a new plant design technology. The software should offer faster deployment and an intuitive graphic user interface (GUI) with mobile access. It offers richer design capabilities that will improve automation and visibility. The company also claim that it will be faster and 20% more efficient than their previous, tried and tested product.

BOSCH had a vast array of products on show. Their Fast Air Lock ISS 1000 allows for the contamination-free transfer of pharmaceutical equipment. It is the 100th isolator sold to the pharmaceutical trade. They also have a unit based on soft x-ray technology for the inspection of filled hard capsules. Their Marvus system consists of a headset with a camera, display, earphones and microphone. This is all for remote service from BOSCH experts. This product is also up for an innovation award.

Other innovations I noted were ATMI’s large array of mixers and bioreactors for single-use technology. Conductive levitation is a unique mixing technology and there is no contact. Meanwhile. Thermo Scientific had a freezer on show that will text you if it starts defrosting. They have also developed an extruder for hot-melt extrusion, in association with BASF.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
8%
All of the above.
42%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here